Highest-materiality recent filing
Danaher Q3 2026 EPS $1.71, adjusted $2.11; revenue $6.6B up 8.5%, FY EPS guidance raised
Net earnings $1.2B, or $1.71 per diluted share, up 34.5% YoY; non-GAAP adjusted diluted EPS $2.11, up 11.5%.
Board expanded to 13 members effective Oct 9, 2026 with appointments of Daniel L. Comas and Robert M. Hershberg, M.D., Ph.D., both serving until the next annual meeting.
Danaher appoints Julie Sawyer Montgomery as CEO effective Oct 1, 2026; Rainer Blair to retire
Julie Sawyer Montgomery named President and CEO effective Oct 1, 2026; also appointed to Board.
Danaher Q2 2026 EPS $1.23 (up 60% YoY), raises full-year adjusted EPS guidance to $8.45-$8.60
Net earnings $870M ($1.23 diluted EPS) up 60% YoY; adjusted EPS $1.94 up 8.0%.
Danaher subsidiary issues CHF 2.38B senior notes across seven tranches with maturities 2031-2056
Issued CHF 2.38B senior notes via private placement; seven series with rates 1.65% to 2.51%.
Danaher shareholders approve Omnibus Incentive Plan, increase share reserve by 20 million shares
Shareholders approved the Amended and Restated Omnibus Incentive Plan, increasing share reserve by 20 million shares and extending term to May 5, 2036.
Danaher issues €3.0B in senior notes to partially fund Masimo acquisition
Issued €500M floating rate notes due 2028, €750M 3.250% notes due 2030, €750M 3.625% notes due 2034, €1B 4.000% notes due 2038.
Danaher Q1 adj EPS $2.06 (+9.5%), revenue $6.0B (+3.5%), raises FY guidance
Net earnings $1.0B, diluted EPS $1.45; adjusted EPS $2.06, up 9.5% YoY.
Danaher enters $5.0B 364-day revolving credit facility with Bank of America
$5.0B 364-day revolving credit facility; expires April 15, 2027, with option to convert to term loans (+0.50% fee).
Danaher to acquire Masimo for $180/share cash, ~$9.9B enterprise value
All-cash deal at $180/share; total enterprise value ~$9.9B including assumed debt.
Board Director Jessica L. Mega retires from Danaher Board effective Feb 5, 2026
Jessica L. Mega retired from Danaher's Board on Feb 5, 2026, due to other professional commitments.
Danaher Q4 adj EPS $2.23 (+4%); revenue $6.8B (+4.5%); FY26 guidance $8.35-$8.50
Q4 2025 adj EPS $2.23 (+4.0%); revenue $6.8B (+4.5%); non-GAAP core revenue +2.5%.
Estimated Q4 2025 revenue up mid-single-digit percent YoY; non-GAAP core revenue growth toward high-end of low-single-digit guidance.
John T. Schwieters has decided not to stand for reelection at Danaher's 2026 annual meeting and will retire from the Board effective as of that meeting.
Danaher Q3 2025: EPS $1.27 GAAP, $1.89 adjusted; revenue up 4.5% to $6.1B
Net earnings $908M ($1.27 diluted EPS); non-GAAP adjusted diluted EPS $1.89.
Danaher authorizes new share repurchase program of up to 35 million shares
Board approved repurchase of up to 35 million shares of common stock, with no expiration date.
Danaher GC Brian Ellis to step down as General Counsel on Aug 25, 2025; retire Feb 2026
Brian W. Ellis, SVP and General Counsel, notified Danaher of plan to relinquish GC role effective August 25, 2025.
Danaher names Matthew Gugino as CFO effective Feb 28, 2026; McGrew to remain EVP
Matthew M. McGrew to step down as CFO effective Feb 28, 2026, continue as Executive Vice President.
Net earnings $555M ($0.77 GAAP diluted EPS); adjusted diluted EPS $1.80.
Elected 13 directors, each receiving majority FOR votes; lowest support was John T. Schwieters with ~420M FOR.
Danaher Q1 adj. EPS $1.88 beats; revenues $5.7B; FY adj. EPS guidance $7.60-$7.75
Net earnings $1.0B ($1.32 GAAP EPS); adjusted diluted EPS $1.88, exceeding expectations.
Danaher appoints Charles W. Lamanna to Board effective Feb 20, 2025
Charles W. Lamanna appointed to Danaher's Board, term expires at 2025 annual meeting; also appointed to Science & Technology Committee.
Danaher Q4 net earnings $1.1B; guides FY2025 core revenue +3%
Q4 EPS $1.49 GAAP, $2.14 adjusted; revenue $6.5B (+2.0% YoY).
Danaher Q4 2024 estimated revs up low-single digit; core revenue flat, beating guidance
Estimated Q4 2024 revenues increase low-single digit percent year-over-year.
Director Pardis C. Sabeti retires from Danaher Board on Dec 10, 2024
Pardis C. Sabeti notified Danaher Board of her retirement effective December 10, 2024, citing time commitments.
Danaher Q3 adj EPS $1.71 beats; revenue $5.8B +3%; guides core rev down low-single digits
Net earnings $818M ($1.12 GAAP EPS); adjusted diluted EPS $1.71, above expectations.
Danaher Q2 revenue down 3% to $5.7B, adjusted EPS $1.72 beats expectations
Net earnings $907M, GAAP diluted EPS $1.22; non-GAAP adjusted EPS $1.72.
Danaher EVP Joakim Weidemanis to step down July 1, 2024; transition through Sept 30
Joakim Weidemanis resigns as Executive Vice President effective July 1, 2024; will remain employed through Sept 30, 2024 for transition.
Danaher shareholders elect all 13 directors; reject two shareholder proposals at 2024 annual meeting
All 13 director nominees elected; notable against votes: Teri List (28.6% against), John Schwieters (35.1%), A. Shane Sanders (26.5%).
Danaher Q1 2024 beats expectations with $5.8B revenue, $1.92 adj EPS
Net earnings $1.1B, diluted EPS $1.45; adjusted diluted EPS $1.92.
Director Walter G. Lohr, Jr. to retire from Danaher board at May 2024 annual meeting
Walter G. Lohr, Jr. notified Danaher board he will not stand for reelection at the May 7, 2024 annual meeting.
Danaher Q4 net earnings $1.1B, EPS $1.50; core revenue down 11.5% YoY
Q4 revenue $6.4B, down 10.0% YoY; non-GAAP core revenue down 11.5%.
Danaher Q4 2023 revenue to decline low-double digits; core revenue above prior guidance
Estimated Q4 2023 revenue decline low-double digits YoY (non-GAAP core revenue decline above prior high-teens guidance).
Danaher Q3 revenue $6.9B, down 10.5% YoY; adj. EPS $2.02; guides Q4 core down mid-single digits
Net earnings $1.1B ($1.51 diluted EPS); adjusted diluted EPS $2.02.
Danaher completes spin-off of Veralto, distributes 246M shares; executive departs
Danaher completed spin-off of Veralto; stockholders received 1 VLTO share per 3 DHR shares held on Sep 13.
Danaher unit Veralto issues $2.1B notes plus €500M; Danaher guarantee ends at spin-off
Veralto issued $700M 5.5% notes due 2026, $700M 5.35% notes due 2028, $700M 5.45% notes due 2033.
Danaher subsidiary Veralto prices $2.1B USD notes and €500M Euro notes for separation financing
Veralto (subsidiary) to sell $700M 5.5% notes due 2026, $700M 5.35% notes due 2028, $700M 5.45% notes due 2033.
Danaher imposes trading blackout on insiders and plan participants due to Veralto spin-off
Blackout begins Sept 29, 2023 at 4pm ET and ends Oct 5, 2023 at 4pm ET.
Danaher subsidiary Veralto Corp enters $1.5B credit facility ahead of spinoff
$1.5B unsecured five-year revolving credit facility maturing August 31, 2028, with one-year extension option.
Danaher enters into $5.0B unsecured revolving credit facility replacing existing facility
New $5.0B unsecured revolver replaces existing facility; expires August 11, 2028 with one-year extension option.
Danaher Q2 GAAP EPS $1.49, adj. $2.05; revenue down 7.5% to $7.2B
Net earnings $1.1B, diluted EPS $1.49; adjusted diluted EPS $2.05.
Danaher eliminates Series A and B Mandatory Convertible Preferred Stock after conversion
Filed Certificate of Elimination for 4.75% Series A and 5.00% Series B Mandatory Convertible Preferred Stock.
Danaher Q1 2023 EPS $1.94 adj $2.36; revenue $7.2B down 7%; base business +6%
Net earnings $1.4B; diluted EPS $1.94; adjusted diluted EPS $2.36.
Danaher Q4 2022 EPS $2.99, revenue $8.4B; full-year core growth 9.5%
Q4 2022 net earnings $2.2B ($2.99 diluted EPS); adjusted EPS $2.87, up 6.5% YoY.
Danaher splits Life Sciences into Biotechnology and Life Sciences segments, effective Q4 2022
New four-segment structure: Biotechnology, Life Sciences, Diagnostics, Environmental & Applied Solutions.
Danaher expects Q4 non-GAAP core revenue growth high-single digits, above prior guidance
Q4 estimated revenues up low-single-digit% YoY; non-GAAP core revenue growth high-single-digit% vs prior flat to low-single-digit decline guidance.
Board amended and restated bylaws effective December 6, 2022.
Danaher Q3 2022 EPS $2.10, revenue $7.7B; guides core growth to high-single digits
Net earnings $1.6B, diluted EPS $2.10 (+36% YoY); adjusted EPS $2.56 (+7% YoY).
Danaher Q2 adj EPS $2.76 (+12% YoY); revenue $7.8B (+7.5%); core growth 9.5%
GAAP diluted EPS $2.25, down 1.5% YoY; non-GAAP adj diluted EPS $2.76, up 12.0% YoY.
Danaher appoints Feroz Dewan to board; board expands to 14 members
Board expanded from 13 to 14 members; Feroz Dewan appointed to fill vacancy on June 27, 2022.
On October 9, 2026, the Board of Directors (the “Board”) of Danaher Corporation (the “Company” or “Danaher”) increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately.
On October 9, Alan G. Spoon notified the Company of his decision to retire as a member of the Board, effective as of the Company’s 2027 annual meeting of shareholders (the “2027 Annual Meeting”). Therefore, Mr. Spoon will not stand for re-election at the 2027 Annual Meeting. Mr. Spoon’s decision to retire is not because of a disagreement with the Company on any matter relating to the Company’s operations, policies or practices, or on any matter relating to any committee of the Board.
On October 9, 2026, the Board of Directors (the “Board”) of Danaher Corporation (the “Company” or “Danaher”) increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately. Each of Mr. Comas and Dr. Hershberg will serve until the Company’s next annual meeting of shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal.
The Board also appointed Ms. Sawyer Montgomery to the Board and to each of the Executive, Finance and Science & Technology Committees of the Board, in each case effective as of the Effective Date.
the Board of Directors of the Company (the “Board”) has appointed Julie Sawyer Montgomery as President and Chief Executive Officer of the Company (the “CEO”).
On February 20, 2025, the Board of Directors (“Board”) of Danaher Corporation (“Danaher” or the “Company”) appointed Charles W. Lamanna to the Board, with a term expiring at Danaher’s 2025 annual meeting of shareholders.
On June 16, 2024, Joakim Weidemanis, Executive Vice President of Danaher Corporation (the “Company” or “Danaher”), notified the Company that he will step down from such position as of July 1, 2024.
Walter G. Lohr, Jr. notified Danaher’s Board of Directors that he has decided not to stand for reelection at the Company’s annual meeting of shareholders to be held on May 7, 2024, and will retire from the Danaher Board as of the annual meeting.
Jennifer L. Honeycutt (Executive Vice President) submitted her resignation from her position as an executive officer at Danaher (but not at Veralto), effective as of the Distribution.
On June 27, 2022, the Board of Directors (“Board”) of Danaher Corporation (“Danaher”) increased the size of Danaher’s Board from thirteen to fourteen members and appointed Feroz Dewan to the Board to fill the newly-created vacancy, with a term expiring at Danaher’s 2023 annual meeting of shareholders.
As previously announced, as of April 1, 2022, Angela S. Lalor has stepped down, and Georgeann F. Couchara has succeeded her, as Senior Vice President-Human Resources.
As previously announced, as of April 1, 2022, Angela S. Lalor has stepped down, and Georgeann F. Couchara has succeeded her, as Senior Vice President-Human Resources.
Max materiality 0.90 · Median 0.65 · Most common event earnings